Suppr超能文献

脓毒性休克合并急性肾损伤患者开始连续性肾脏替代治疗的时机。

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.

作者信息

Shum Hoi-Ping, Chan King-Chung, Kwan Ming-Chit, Yeung Alwin Wai-Tak, Cheung Emily Wing-Sze, Yan Wing-Wa

机构信息

Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.

出版信息

Ther Apher Dial. 2013 Jun;17(3):305-10. doi: 10.1111/j.1744-9987.2012.01147.x. Epub 2012 Dec 7.

Abstract

The optimal timing for renal replacement therapy initiation in septic acute kidney injury (AKI) remains controversial. This study investigates the impact of early versus late initiation of continuous renal replacement therapy (CRRT) on organ dysfunction among patients with septic shock and AKI. Patients were dichotomized into "early" (simplified RIFLE Risk) or "late" (simplified RIFLE Injury or Failure) CRRT initiation. Patients with chronic kidney disease stage 5 or those on long-term dialysis were excluded. Organ dysfunction was quantified by Sequential Organ Failure Assessment (SOFA) score. From January 2008 to June 2011, 120 patients fulfilled the inclusion criteria. Thirty-one (26%) underwent "early" while 89 (74%) had "late" CRRT. No significant difference was noted between groups on improvement of total SOFA/non-renal SOFA score or noradrenaline equivalent in the first 24 and 48 h after CRRT initiation. Dialysis requirement and mortality (at 28 days, 3 months and 6 months) did not differ. In conclusion, improvement of non-renal SOFA score 48 h after CRRT correlated with SOFA score on CRRT initiation (P = 0.040) and APACHE IV risk of death (P = 0.000), but not estimated glomerular filtration rate on CRRT initiation (P = 0.377). Improvement of non-renal SOFA score correlated with SOFA score on CRRT initiation and APACHE IV risk of death. However, this retrospective review cannot identify any significant clinical benefit of early CRRT initiation in patients presenting with septic shock and AKI.

摘要

脓毒症急性肾损伤(AKI)中开始肾脏替代治疗的最佳时机仍存在争议。本研究调查了脓毒症休克合并AKI患者早期与晚期开始连续性肾脏替代治疗(CRRT)对器官功能障碍的影响。患者被分为“早期”(简化RIFLE风险)或“晚期”(简化RIFLE损伤或衰竭)开始CRRT。排除慢性肾脏病5期患者或长期透析患者。通过序贯器官衰竭评估(SOFA)评分对器官功能障碍进行量化。2008年1月至2011年6月,120例患者符合纳入标准。31例(26%)接受“早期”CRRT,89例(74%)接受“晚期”CRRT。CRRT开始后最初24小时和48小时,两组在总SOFA/非肾脏SOFA评分改善或去甲肾上腺素等效剂量方面无显著差异。透析需求和死亡率(28天、3个月和6个月时)无差异。总之,CRRT开始48小时后非肾脏SOFA评分的改善与CRRT开始时的SOFA评分(P = 0.040)和APACHE IV死亡风险(P = 0.000)相关,但与CRRT开始时的估计肾小球滤过率无关(P = 0.377)。非肾脏SOFA评分的改善与CRRT开始时的SOFA评分和APACHE IV死亡风险相关。然而,这项回顾性研究未能发现早期CRRT对脓毒症休克合并AKI患者有任何显著的临床益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验